22/07/2010
XXXIII World Congress of the International Society of Hematology: Poster Presentation
ERYtech Pharma will present a poster at the XXXIII World Congress of the International Society of Hematology, October 10-13, Jerusalem, Israel.
Learn more21/07/2010
BioPharm America 2010
BioPharm America 2010: September 15-17, 2010, Boston-USA
Learn more20/07/2010
French Biotech Tour
French Biotech Tour: September 14, 2010, Philadelphia, PA, USA.
Learn more24/06/2010
ESH International Conference: Poster Presentation
ERYtech Pharma will present a poster at the ESH International Conference on Haematological Malignancies In The Elderly, July 2-4, 2010, Lisbon, Portugal.
Learn more14/06/2010
EACR21: Poster presentation
ERYtech Pharma will present a poster at the 21st Meeting of the European Association for Cancer Research, June 26-29, 2010, Oslo Norway.
Learn more03/06/2010
EHA
15th Congress of EHA, June 10-13, 2010, Barcelona, Spain
Learn more19/05/2010
ASCO
46th ASCO Annual Meeting, June 4–8, 2010, McCormick Place,Chicago, IL, USA
Learn more18/05/2010
ISCT 2010: Poster presentation
ERYtech Pharma will present a poster at the 16th Annual ISCT Meeting in Philadelphia, May 22-26 2010
Learn more18/05/2010
ISCT 2010: Oral presentation
ERYtech Pharma will present an oral communication at the 16th Annual ISCT Meeting in Philadelphia, May 22-26 2010
Learn more03/05/2010
The 5th European Conference on Rare Diseases
The 5th European Conference on Rare Diseases, May 13-15, Krakow, Poland
Learn more15/04/2010
7th International Congress on Autoimmunity
7th International Congress on Autoimmunity: Poster presentation
May 5-9, 2010 Ljubljana, Slovenia
Learn more14/04/2010
Bio 2010
Bio 2010
May 3-6, 2010 McCormick Place Chicago, IL, USA
Learn more13/04/2010
EHA - ESH
EHA – ESH: Poster presentation
April 15-18, 2010, Cascais, Portugal
Learn more07/04/2010
International recognition of the ERYtech Pharma R&D platform.
ERYtech Pharma is proud to announce that a number of recent advances of the ongoing program will be published in leading scientific journals.
In the next coming weeks, the company will furthermore present the R&D technology platform at several international scientific conventions.
Learn more02/04/2010
Publication in Vaccine
ERYtech Pharma announces the publication of an article concerning its immuno-stimulation application – GrVax in the internationally recognized Vaccine scientific journal (Elsevier): ‘’ In situ targeting of dendritic cells by antigen-loaded red blood cells: A novel approach to cancer immunotherapy ‘’
Learn more29/03/2010
5èmes Journées Scientifiques du CLARA
March 30-31: 5èmes Journées Scientifiques du CLARA, Villeurbanne, France
Learn more23/03/2010
GRASPA® in The Ones To Watch
GRASPA® is cited among the Five Most Promising Drugs Entering Phase III Trials
Learn more15/03/2010
TIDES 2010
TIDES 2010: Oral presentation - Boston - April 25-28
Learn more15/02/2010
Press Release February 15
ERYtech Pharma signs an agreement with M. D. Anderson Cancer Center to develop a companion test for GRASPA® in solid tumors
Learn more10/02/2010
BIO-Europe Spring®
March 8–10: BIO-Europe Spring® 2010 - Barcelona - Spain
Learn more09/02/2010
Franco-British Business Exchange on Oncology
March 2-3 : Franco-British Business Exchange on Oncology, CCI, Lyon - France
Learn more26/01/2010
Press Release January 26 2010
FDA grants Orphan Drug Designation to GRASPA® for treatment of Acute Lymphoblastic Leukaemia.
Learn more09/12/2009
Poster at the 2nd International Workshop on “Plasmacytoid Dendritic Cells and Immune Responses”
17-18 December 2009: Poster presentation -2nd International Workshop on “Plasmacytoid Dendritic Cells and Immune Responses” - Paris
Learn more03/12/2009
ASH 2009
ASH - New Orleans, December 5-8, 2009
Learn more24/11/2009
Press Release November 24 2009
ERYtech Pharma has been awarded ISO 9001:2008 Certification.
Learn more05/11/2009
Press Release November 5 2009
ERYtech Pharma starts its pivotal clinical trial for GRASPA® in Acute Lymphoblastic Leukaemia.
Learn more29/10/2009
Press Release October 2009
ERYtech Pharma reinforces its Supervisory Board and its Scientific Board.
Learn more27/10/2009
French American Scientific Track workshop
Oral presentation on the French American Scientific Track workshop on October 27th in Boston
Learn more26/10/2009
Bio-Europe 2009
BIO-Europe 2009, Vienna, Austria November 2-4, 2009.
Learn more09/10/2009
MVADS
October 28-30: Oral presentation - 3rd International Conference on Modern Vaccines Adjuvants & Delivery Systems, Vienna, Austria
Learn more08/10/2009
Ist International Conference on Immune Tolerance
October 25-27: Ist International Conference on Immune Tolerance - Boston – USA.
Learn more18/09/2009
Annual Pancreatic Cancer Symposium
September 25: Annual Pancreatic Cancer Symposium,Marseille (France)
Learn more27/08/2009
Biotech in Europe Investor Forum
September 14-15: 9th Annual Biotech in Europe Investor Forum - Zurich, Switzerland
Learn more26/08/2009
Symbiosis Barcelona
September 13-16: 14th European Congress on Biotechnology – Symbiosis - Barcelona, Spain
Learn more25/08/2009
ECI Berlin
September 13-16: 2nd European Congress of Immunology - ECI - Berlin, Germany
Learn more24/08/2009
GTRV Lausanne
GTRV - September 3-4, Lausanne, Switzerland.
Learn more18/06/2009
EPIC 2009
June 25: EPIC, London
Learn more05/06/2009
BioEquity Europe 2009
June 9 - 10: BioEquity Europe 2009, Munich, Germany
Learn more27/05/2009
EHA 2009
June 4 - 5: EHA 2009 - Berlin, Germany
Learn more25/05/2009
SFSTP
June 3-4: SFSTP, Le corum , Montpellier, France
Learn more14/05/2009
Press release May 2009
ERYtech Pharma announces that it has started a phase II clinical trial with GRASPA® as first-line treatment among patients with acute lymphoblastic leukaemia (ALL) aged 55 and older.
Learn more04/05/2009
Bio 2009
May 18-21: Bio 2009 - Atlanta, USA
Learn more21/04/2009
EPPOSI
22 April : EPPOSI - Brussels
Learn more20/04/2009
BioCapital Europe
April 21: BioCapital Europe 2009,Amsterdam, The Netherlands
Learn more16/04/2009
Press Release April 2009
ERYtech Pharma will present very encouraging results of its R&D platform at the annual meeting of the American Association of Cancer Research at the Colorado Convention Center inDenver (CO) between 18th to 21th April.
Learn more30/03/2009
AACR
April 18 - 22: 100th Annual Meeting 2009 of the AACR - Denver, USA
Learn more25/03/2009
FABS
March 30-31: FABS – ENS, Lyon – France
Learn more24/03/2009
10th Annual Colloquium - Bethesda
10th Annual Colloquium Measuring the Effect of Cancer Immunotherapies - March 26-28 - Bethesda, USA
Learn more13/03/2009
Press Release March 2009
ERYtech Pharma is authorized to open its pharmaceutical manufacturing site.
Learn more03/03/2009
Bio-Europe Spring
March 16-18: Bio-Europe Spring, Milano Convention Center, Milan, Italy
Learn more03/03/2009
Biosquare 2009
March 9 - 11: BioSquare, Lyon Congress Center
Learn more09/02/2009
BioBusiness 2009
BioBusiness 2009 in Geneva - February 17-18, 2009
Learn more13/01/2009
Press Release January 2009
ERYtech Pharma signs an agreement with the Penn Jersey Region of American Red Cross
Learn more10/12/2008
Press Release December
ERYtech Pharma announces the results of its phase II clinical trial
Learn more27/11/2008
Poster “An Assay to Predict L-Asparaginase Neutralization and Enzyme Loaded Red Blood Cells to Maintain in Vivo Efficacy” at the ASH 2008
Poster “An Assay to Predict L-Asparaginase Neutralization and Enzyme Loaded Red Blood Cells to Maintain in Vivo Efficacy” at the ASH congress in San Francisco on 6-9 December
Learn more27/11/2008
Poster “Allosteric Hemoglobin Effector Loaded Erythrocytes improve the Efficiency of Transfusion to Prevent sickling” at the ASH 2008
Poster “Allosteric Hemoglobin Effector Loaded Erythrocytes improve the Efficiency of Transfusion to Prevent sickling” at the ASH congress in San francisco on 6-9 December
Learn more27/11/2008
Oral presentation “GRASPALL 2005.01 Clinical Study: L-Asparaginase Loaded into Red Blood Cells Is Effective at Depleting Serum Asparagine in Children and Adults with Relapsed Acute Lymphoblastic Leukaemia (ALL)” at the ASH congress in San Francisco on 6-9 December Monday, December 8, 2008: 12:15 PM
Oral presentation “GRASPALL 2005.01 Clinical Study: L-Asparaginase Loaded into Red Blood Cells Is Effective at Depleting Serum Asparagine in Children and Adults with Relapsed Acute Lymphoblastic Leukaemia (ALL)” at the ASH congress in San Francisco on 6-9 December Monday, December 8, 2008: 12:15 PM
Yerba Buena Ballroom Salon 9 (San Francisco Marriott)
Learn more20/11/2008
Press Release November
ERYtech Pharma presents a new advance in the treatment of sickle cell anaemia
Learn more05/11/2008
Bio Europe 2008
Bio Europe 2008 - Mannheim - November 16-19
Learn more31/10/2008
ISPOR
ISPOR - Athens - November 8-11, 2008
Learn more31/10/2008
BIOTECH 2008
BIOTECH 2008 - November 10/11 - Philadelphia.
Learn more28/10/2008
Press Release October 2008
ERYtech Pharma proposes new anticancer vaccine technology
Learn more09/10/2008
9th Workshop on Partnering for Rare Desease - October 16-17, 2008 - Paris
09/10/2008
6th International Cancer Vaccine Symposium - October 28-30, 2008 - New York
08/10/2008
World Vaccine Congress - October 6-9, 2008 -Lyon
08/10/2008
Eurobio - October 7-9, 2008 - Paris
07/10/2008
BIOCONTACT QUEBEC October 1-3
07/10/2008
AABB Annual Meeting - Palais des Congrès of Montréal, October 4-7 2008
01/10/2008
Recipient ANR BiotechS
ERYtech Pharma recognized by the ANR, the French National Research Agency
Learn more15/09/2008
ERYtech Pharma enlarges its In Vitro Lab
09/09/2008
"12èmes journées du GPCO"- Marseille - September 25/26
29/08/2008
Biotech in Europe Investor Forum - Zurich - September 23/24
29/08/2008
BioBusiness Network, September 16-18 - Geneva
12/06/2008
ERYtech Pharma US Office
ERYtech Pharma establishes in the USA and selects the Philadelphia Science Center as US Headquarters.
Learn more11/06/2008
Bio 2008, June 17-20 - San Diego
03/06/2008
EHA - Copenhagen - June 12/15 2008
13/05/2008
ERYtech Pharma will be present on ILSI BioMed 2008 – Tel-Aviv
28/04/2008
ERYtech Pharma reinforces its Management Team
ERYtech Pharma reinforces its Management Team with Dr David Liens as CMO and Philippe Dujardin as CFO and has appointed Dr Véronique Sézanne as the Qualified Person
Learn more25/04/2008
EPIC Biotech 2008 - London - May 22
25/04/2008
5th Annual Healthcare Conference Rodman & Renshaw - Monte Carlo, May 19-20
28/03/2008
FABS and FABZ - La Jolla April 1-4, 2008
28/03/2008
BIO-Europe Spring 2008, Madrid - April 7-9
06/02/2008
ERYtech Pharma is selected for an Oral Presentation at The Acute Leukemias XII Symposium in Munich, Germany - February 16-20, 2008
06/02/2008
ERYtech Pharma will present two posters at the Acute Leukemias XII Symposium, in Munich, Germany February 16-20, 2008
28/01/2008
ERYtech Pharma will present a poster at The Lysosomal Disease Network - Las Vegas - February 13-15, 2008
20/12/2007
BIO-Asia 2008
29/11/2007
ERYtech Pharma is very proud to announce Pr. Jacques DESCOTES, joins the Scientific Committee.
ERYtech Pharma is very proud to announce Pr. Jacques DESCOTES, M.D., Pharm.D., Ph.D. joins the Scientific Committee.
Learn more27/11/2007
ASH in Atlanta on December 7-11, 2007.
ERYtech Pharma will be present at the ASH in Atlanta on December 7-11, 2007.
Learn more07/11/2007
New address
ERYtech Pharma transfers all its Office and facilities
Learn more24/10/2007
Bio Europe - Hamburg
ERYtech Pharma will attend the Bio Europe Convention in Hamburg,
Learn more24/10/2007
Véronique Sézanne joins ERYtech Pharma as Regulatory Affairs Director
Véronique Sézanne, PharmD, joins ERYtech Pharma as Regulatory Affairs Director.
Learn more27/07/2007
Press Release, July 2007
Lyon, (France), July, 16th 2007 – ERYtech Pharma strengthens its Team and starts its international development.
Learn more30/03/2007
Bio- Boston
ERYtech Pharma will attend the Bio International Convention in Boston- MA on May 6-9 2007.
Learn more21/03/2007
Poster SFH
ERYtech Pharma will present a poster ''Encapsulation de L-Asparaginase dans les Erythrocytes - Principe et Intérêts'' Y. Godfrin and Y. Bertrand, on the SFH - March 22-24 2007 at the Maison de la Chimie, Paris.
Learn more19/01/2007
ERYtech Pharma raises €12 million to boost its development.
Lyon, (France), 22 December 2006 – ERYtech Pharma, the biotech company specialized in red blood cell encapsulation of drugs, is pleased to announce the successful completion of a €12 million fund-raising.
This round brings together AGF Private Equity (Thierry Laugel), Auriga Partners (Franck Lescure) and AXA Private Equity (Glenn Richard) along with its original investors, including CapDecisif (Jérôme Snollaerts) and Amorçage Rhône Alpes (Karine Lignel).
Learn more05/10/2006
GRASPA® RECEIVES POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION
ERYTECH PHARMA, a biopharmaceutical company specialized in the encapsulation of therapeutic molecules and enzymes into Red Blood Cells, today announced that the Innovation Task Force (ITF), a division of the European Medicines Agency (EMEA) has approved regulatory classification for GRASPA® (L-Asparaginase encapsulated in Erythrocyte) as medicinal product, eligible for EMEA procedures.
Learn more22/06/2006
Lyon, June 2006
ERYtech Pharma announces that his surface of laboratory has been increased threefold...
Learn more17/01/2006
Meet ERYtech Pharma at major international events
ERYtech Pharma’s representatives will attend major biotech and life sciences events in the forthcoming months...
Learn more02/01/2006
ERYtech Pharma welcomes new colleagues and opens an office in Paris
ERYtech Pharma's team enlarges to 8 people as it welcomes two new members, Thomas Vigneron as Projects & Quality Manager, and David Salako as Clinical Affairs Manager ...
Learn more03/11/2005
ERYtech Pharma achieves its fund raising and starts a Phase II clinical trial
ERYtech Pharma, a French biopharmaceutical company specialized in the encapsulation of therapeutic molecules into red blood cells, announces today the closing of its first financing round...
Learn more30/06/2005
ERYtech Pharma and the anticancer Centre Léon Bérard sign a five year R&D partnership
ERYtech Pharma announces the renewal of its partnering convention with the Centre Léon Bérard for another five years ...
Learn more29/06/2005
ERYtech Pharma receives an award from the French Ministry of Research
ERYtech Pharma has been granted an award from the French Ministry of Research for its innovative activity and technology ...
Learn more02/11/2004
The biotechnology company ERYtech Pharma is officially founded
The French biotechnology ERYtech Pharma announces today its official foundation. After a period of incubation in Crealys, the ERYtech Pharma project has now turned into a promising company...
Learn more30/06/2004
The ERYtech Pharma project receives an award from the French Ministry of Research
ERYtech Pharma has been granted a 40 000 euro award from the French Ministry of Research ...
Learn more01/06/2004
The ERYtech Pharma project starts its incubation phase at Crealys
The ERYtech Pharma project, based on the encapsulation of therapeutic molecules or enzymes into red blood cells...
Learn more
